Entera Bio (ENTX) Cash from Operations Growth (1y) (2022 - 2026)
Entera Bio (ENTX) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Entera Bio |
57.79 Mn |
53.65 Mn |
- |
-120.09% |
| Date | Value |
|---|
| Mar 31, 2026 |
-120.09% |
| Dec 31, 2025 |
-24.95% |
| Sep 30, 2025 |
-16.16% |
| Jun 30, 2025 |
-22.17% |
| Mar 31, 2025 |
24.60% |
| Dec 31, 2024 |
43.94% |
| Sep 30, 2024 |
-41.25% |
| Jun 30, 2024 |
14.37% |
| Mar 31, 2024 |
-15.72% |
| Dec 31, 2023 |
-30.13% |
| Sep 30, 2023 |
46.85% |
| Jun 30, 2023 |
44.85% |
| Mar 31, 2023 |
66.42% |
| Dec 31, 2022 |
19.94% |
| Sep 30, 2022 |
-36.04% |
| Jun 30, 2022 |
-33.29% |
| Mar 31, 2022 |
-106.46% |
